Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Value sales of analgesics in France continue to record solid growth in 2023 following a dynamic performance the previous year. The key growth driver is the increasing demand for acetaminophen, with the brand Doliprane from Sanofi, convincingly…
Analgesics has experienced a fluctuating performance in the last few years, as demand has been significantly impacted by the dramatic changes to consumer lifestyles resulting from the COVID-19 crisis. With the outbreak of COVID-19 in 2020, many…
Sales of analgesics return to their pre-pandemic performance in 2023. After the pandemic, seasonal colds and flus circulated more in the country as consumers socialised more without wearing masks, and sales of analgesics have returned to their usual…
Regional differences and the standard of living in the area greatly influences consumer buying behaviour. Regions have different cultural and social norms that impact the types of products that are purchased and the way they are marketed. For…
Pharmacies continue to have significant influence over the value sales of analgesics in Ecuador. For instance, in lower income neighbourhoods, pharmacies are generally stocked with generics, whereas in wealthier neighbourhoods, mainly branded…
Analgesics has not seen a positive performance in 2023 as the height of the pandemic has passed. During the pandemic’s peak, consumers were buying up analgesics at a rapid pace to treat fevers, aches and other symptoms associated with acute…
Following strong growth between 2020 and 2022, analgesics saw much more moderate current value growth in 2023 as the COVID-19 pandemic began to wane. Rising inflation as a result of the energy crisis stemming in part from the war in Ukraine is…
Growth of analgesics in 2023 can be mainly attributed to the full recovery of daily activity post pandemic. The main contributors here were the full operation of manual labour intensive industries (predominantly construction), a stronger flu season…
Rising inflation has caused consumers to be increasingly stressed in 2023, with rising price points and ongoing economic uncertainty negatively impacting lives. This ongoing uncertainty has led to an increase in physical discomforts; often in the…
After the spike in demand for systemic analgesics in the period, 2020 to 2021, driven by COVID-19 and then by the need to relieve reactions to vaccination, in 2022 demand tended to stabilise. However, adult acetaminophen and combination analgesics…
Even after seeing exceptional current value growth in 2022, it is anticipated that analgesics will continue to experience double-digit growth in 2023. This can primarily be attributed to the substantial increase in COVID-19 cases in China starting…
In 2023, acetaminophen continues to lead sales of analgesics in Chile, whilst also experiencing the highest growth rate in the category. This growth has remained steady since the onset of the pandemic, where acetaminophen became the preferred choice…
Systematic analgesics is expected to register positive retail value (constant 2023 prices) growth over 2023, after a spike in 2022 driven by very strong demand for paediatric analgesics, as well as fast demand for adult pain relief, as respiratory…
Consumers are increasingly embracing self-medication, especially for minor illnesses, and this contributed to modest growth in 2023, as well as continuing population growth. Analgesics have achieved a substantial penetration rate in Cameroon,…
The analgesics market in Bulgaria has reached a mature stage, characterised by steady growth and well-established product offerings. This maturity is evident in the consistent demand for pain relief solutions driven by factors such as an ageing…
Analgesics is set to maintain steady current value growth in Brazil in 2023, and will remain the largest category within OTC, with a 40% share of value sales. The consumption of analgesics is mainly related to general pain, fever, and the relief of…
Analgesics achieved strong double-digit growth in 2023 amidst stable consumer demand and rising unit prices caused by inflation. Systemic analgesics is outperforming topical analgesics in 2023, a trend that has been prevalent throughout the review…
While analgesics performed well during the pandemic, they has returned to more moderate growth now that the threat has subsided. In 2023, analgesics is expected to register moderate current value growth, though constant value sales are expected to…
Sales of analgesics are seeing robust growth in current value terms in 2023, continuing on from the steady performance seen in 2022. During 2022, sales of analgesics benefited from a sudden peak in cases of flu in the middle of the winter. This was…
In 2023, the COVID-19 pandemic has lost some of its disruptive potency; however, analgesic sales in Azerbaijan are ticking upwards in value terms (with the exception of adult aspirin). Value sales are being pushed by Azerbaijan's reliance on imports,…